Review of 10 years of the clinical use of brain natriuretic peptide in cardiology

Journal of Laboratory and Clinical Medicine

Volumn 134, Issue 5, 1999, Pages 437-444

  Valli, Nathalie ^a   Gobinet, Agnès ^b   Bordenave, Laurence ^b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARDIOLOGY;

EID: 0033231214     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90163-4     Document Type: Article

References (79)

1. 1. Sudoh T, Kangawa K, Minamino N, Matsuo H. A natriuretic peptide in porcine brain. Nature 1988;322:78-81.
2. 2. De-Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89-94.
3. 3. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide: a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990;168:863-70.
4. 4. Stein BC, Levin R. Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 1998;135:914-23.
5. 5. Nakao K, Ogawa Y, Suga S, Imura H. Molecular biology and biochemistry of the natriuretic peptide system I: natriuretic peptides. J Hypertens 1992;10:907-12.
6. 6. Struthers AD. Natriuretic peptides in congestive heart failure: more than just markers. In: Coats A, Cleland JGF, editors. Controversies in the management of heart failure. Guildford: Churchill Livingstone; 1997. p. 133-46.
7. 7. Tamura N, Ogawa Y, Yasoda A, Itoh H, Saito Y, Nakao K. Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes. J Mol Cell Cardiol 1996;28:1811-5.
8. 8. Takeda T, Kohno M. Brain natriuretic peptide in hypertension. Hypertens Res 1995;259-66.
9. 9. Nakamura S, Naruse M, Naruse K, Kawana M, Nishikawa T, Hosoda S, et al. Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes. Am J Hypertens 1991;4:909-12.
10. 10. Hasegawa K, Fujiwara H, Doyama K, Mukoyama M, Nakao K, Fujiwara T, et al. Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. Am J Pathol 1993;142:107-16.
11. 11. Wei CM, Heutlein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CGA, et al. Natriuretic peptide system in human heart failure. Circulation 1993;88:1004-9.
12. 12. Holmes SJ, Espiner BA, Richards AM, Yandle TG, Frampton C. Renal, endocrine and haemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993;76:91-6.
13. 13. Suga S, Nakao K, Hosoda S, Mukoyama M, Ogawa Y, Shirakami G, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1989;130:229-39.
14. 14. Levin ER. Natriuretic peptide C-receptor: more than a clearance receptor. Am J Physiol 1993;264:E483-9.
15. 15. Mukoyama M, Nakao K, Obata K. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun 1991;180:431-6.
16. 16. Protter AA, Wallace AM, Ferraris VA, Weishaar RE. Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. Am J Hypertens 1996;9:432-6.
17. 17. Jensen KT, Carstens J, Pedersen EB. Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol 1998;274:F63-72.
18. 18. Jensen KT, Carsens J, Ivarsen P, Pedersen EB. A new fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997;57:529-40.
19. 19. Murdoch DR, Byrne J, Morton JJ, McDonagh TA, Robb SD, Clements S, et al. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart 1997;78:594-7.
20. 20. Davidson NC, Coutie WJ, Struthers AD. N Terminal proatrial natriretic peptide and brain natriuretic peptide are stable for up to 6 hours in whole blood in vitro. Circulation 1995;91:1276.
21. 21. Bevilacqua M, Vago T, Baldi G, Norbiato G. Analytical agreement and clinical correlates of plasma natriuretic peptide measured by three immunoassays in patients with heart failure. Clin Chem 1997;43:2439-40.
22. 22. Clerico A, Iervasi G, Del Chicca MG, Emdin M, Maffei S, Nannipieri M, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 1998;21:170-9.
23. 23. Wallèn T, Landahl S, Hedner T, Saito Y, Masuda I, Nakao K. Brain natriuretic peptide in an elderly population. J Intern Med 1997;242:307-11.
24. 24. Yoshibayashi M, Kamiya T, Saito Y, Nakao K, Nishioka K, Temma S, et al. Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 1995;133: 207-9.
25. 25. The SOLVD investigators. Effects of enalapril on mortality and development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992;321:685-91.
26. 26. The SAVE investigators. Effects of captopril on mortality and morbidity in patients with left dysfunction after myocardial infarction. N Engl J Med 1991;327:669-77.
27. 27. Motwani JG, McAlfine H, Kennedy N, Struthers AD. Plasma BNP as an indicator for angiotensin-converting enzyme inhibition after myocardial infartion. Lancet 1993;341:1109-13.
28. 28. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system? J Clin Invest. 1991;87:1402-12.
29. 29. Morita E, Yasue H, Yoshimura M, Okumura K, Ogawa H, Kugiyama K, et al. Increased plasma level of BNP in patients with acute myocardial infarction. J Am Coll Cardiol 1993;88:82-91.
30. 30. Choy AM, Darbar D, Lang CC, Pringle TH, McNeill GP, Kennedy NSJ, et al. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical echographic and neurohormonal methods. Br Heart J 1994;72;16-22.
31. 31. Omland T, Aakvaag A, Bonarjee VVS, Caidahl K, Lie RT, Nielsen DWT, et al. Plasma BNP as an indicator of left ventricular function and long term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N terminal proatrial natriuretic peptide. Circulation 1996;93:1963-9.
32. 32. Arad M, Elazar E, Shotan A, Klein R, Rabinowitz B. Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure. Cardiology 1996;87:12-7.
33. 33. Grantham JA, Burnett JC. BNP: increasing importance in the pathophysiology and diagnosis of congestive heart failure. Circulation 1997;96:388-90.
34. 34. Mukoyama M, Nakao K, Saito Y, Ogawa H, Hosoda K, Suga S, et al. Increased human brain natriuretic pepide in congestive heart failure. N Engl J Med 1990;323:757-8.
35. 35. Yoshimura M, Yasue H, Okumura M, Ogawa H, Jougasaki M, Mukoyama M, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464-9.
36. 36. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localisation and mechanism of secretion of B type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
37. 37. Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 1996;76:232-7.
38. 38. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-94.
39. 39. Davidson NC, Naas AA, Hanson JK, Kennedy NSJ, Coutie WJ, Struthers AD. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 1996;77:828-31.
40. 40. Friedl W, Mair J, Thomas S, Pichler M, Puschendorf B. Natriuretic peptides and cyclic guanosine 3′,5′-monophosphate in asymptomatic and symptomatic left ventricular dysfunction. Heart 1996;76:129-36.
41. 41. Murders F, Kromer EP, Griese DP, Pfeifer M, Hense HW, Reigger GAJ, et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J 1997;134:442-9.
42. 42. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary case. Lancet 1997;350:1349-53.
43. 43. Yamada Y, Goto J, Yokoto M. Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular dysfunction in elderly patients with cardiovascular disease. Cardiology 1997;88:401-7.
44. 44. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrisson CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
45. 45. Daggubati S, Parks JR, Overton RM, Cintron G, Shocken DD, Vesely DL. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain and C-natriuretic prohormone peptides compared as early heart failure indicators. Cardiovasc Res 1997;36:246-55.
46. 46. Davis M, Espiner E, Richards G, Billings J, Town I, Neill A, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994;343:440-4.
47. 47. Fleisher D, Espiner AE, Yandle TG, Livesey JH, Billings J, Town I, et al. Rapid assay of plasma brain natriuretic peptide in the assessment of acute dyspnoea. NZ Med J 1997;110:71-4.
48. 48. Lang CC, Prasad N, McAlpine HM, Macleod C, Lipworth BJ, MacDonald TM, et al. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J 1994;127:1635-6.
49. 49. Cheung BM. Plasma concentration of brain natriuretic peptide is related to diastolic function in hypertension. Clin Exp Pharmacol Physiol 1997;24:966-8.
50. 50. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K et al. Human brain natriuretic peptide a novel cardiac hormone. Lancet 1990;335:801-2.
51. 51. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioda K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92:29-34.
52. 52. Tanaka M, Ishizaka Y, Tshiyama Y, Kato J, Kida O, Kitamura K, et al. Exercise induced secretion of brain natriuretic peptide in essential hypertension and normal subjects. Hypertens Res 1995;18:152-66.
53. 53. Nishikimi T, Yoshihara F, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996;28:22-30.
54. 54. Tomiyama H, Kushiro T, Imai S, Suzuki Y, Akutsu N, Ebuchi T, et al. Changes in E/A ratio induced by handgrip-exercise are related to changes in the plasma atrial natriuretic peptide level, but not changes in brain natriuretic peptide in mild essential hypertension. Jpn Circ J 1995;59:617-23.
55. 55. Kohno M, Yasunari K, Yokokawa K, Horio T, Minami M, Ikeda M, et al. Plasma brain natriuretic peptide during ergometric exercise in hypertensive patients with left ventricular hypertrophy. Metabolism 1996;45:1326-9.
56. 56. Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda N, Minami M, et al. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med 1995;98:257-65.
57. 57. Kikuta K, Yasue H, Yoshimura M, Morita E, Sumida H, Kato H, et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 1996;132:101-7.
58. 58. Mitaka C, Hirata Y, Nagura T, Tsunoda Y, Itoh M, Amaha K. Increased plasma concentration of brain natriuretic peptide in patients with acute lung injury. J Crit Care 1997;12:66-71.
59. 59. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998;31:202-8.
60. 60. Ando T, Ogawa K, Yamaki K, Hara M, Takagi K. Plasma concentrations of atrial, brain, and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory diseases. Chest 1996;110:462-8.
61. 61. Cargill RI, Lipworth BJ. The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature. Br J Clin Pharmacol 1995;40:11-8.
62. 62. Cargill RI, McFarlane LC, Coutie WJ, Lipworth BJ. Acute neurohormonal responses to hypoxaemia in man. Eur J App Physiol 1996;72:256-60.
63. 63. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-32.
64. 64. Darbar D, Davidson NC, Gillespie N, Choy AM, Lang CC, Shyr Y, et al. Diagnostic value of B-type natriuretic peptide concentration in patients with acute myocardial infarction. Am J Cardiol 1996;78:284-7.
65. 65. Arakawa N, Nakamura M, Aoki H, Kiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute MI. J Am Coll Cardiol 1996;27:1656-61.
66. 66. Nagaya N, Nishikimi T, Goto Y, Miyao Y, Kobayashi Y, Morii I, et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J 1998;135:21-8.
67. 67. Wallèn T, Landahl S, Hedner T, Nakao K, Saito Y. Brain natriuretic peptide predicts mortality in the elderly. J Intern Med 1997;77:264-7.
68. 68. Lazzeri C, La Villa G, Bisi G, Boddi V, Messeri G, Strazzulla G, et al. Cardiovascular function during brain natriuretic peptide infusion in man. Cardiology 1995;86:396-401.
69. 69. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki, M, Kurose M, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991;84:1581-8.
70. 70. Yasue H, Yoshimura M. Natriuretic peptides in the treatment of heart failure. J Card Fail 1996;2(suppl):S277-85.
71. 71. Nakamura M, Arakawa N, Yoshida H, Makita S, Niinuma H, Hiramori K. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure. Am Heart J 1998;135:414-20.
72. 72. Hobbs RE, Miller LW, Bott-Silverman C, James KB, Rincon G, Grossbard EB. Hemodynamic effects of single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic cardiomyopathy. Am J Cardiol 1996;78:896-901.
73. 73. Clarkson PB, Wheeldon NM, MacFadyen RJ, Pringle SD, MacDonald TM. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. Circulation 1996;93:2037-42.
74. 74. Richards AM, Crozier IG, Holmes SJ, Espiner EA, Yandle TG, Frampton C. Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension. J Hypertens 1993;11:163-70.
75. 75. Lazzeri C, Franchi F, Porciani C, Fronzaroli C, Casini Raggi V, De Feo ML, et al. Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension. Am J Hypertens 1995;8:799-807.
76. 76. Okumura K, Yasue H, Fujii H, Kugiyama K, Matsuyama K, Yoshimura M, et al. Effect of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables. J Am Coll Cardiol 1993;72:128-33.
77. 77. Kato H, Yasue H, Yoshimura M, Tanaka H, Miyao Y, Okumura K, et al. Suppression of hyperventilation-induced attacks with infusion of B-type (brain) natriuretic peptide in patients with variant angina. Am Heart J 1994;128:1098-4.
78. 78. Cargill RI, Lipworth BJ. Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale: hemodynamic and endocrine effects. Chest 1996;110:1220-5.
79. 79. Lang CC, Motwani J, Coutie WJ, Struthers AD. Influence of candoxatril on plasma brain natriuretic peptide in heart failure. Lancet 1991;338:255.